4 July 2024
Assura plc
("Company")
Result of
AGM
Assura plc announces that at its
Annual General Meeting held earlier today, each of the resolutions
submitted to the meeting (as set out in the Notice of the Meeting
dated 1 June 2024) were passed by the
requisite majorities on a poll.
Resolution
|
For
|
%
For
|
Against
|
%
Against
|
Total Votes Cast (% of issued share capital)
|
Votes Withheld
|
1. To receive the Company's report
and accounts
|
2,504,731,758
|
99.96
|
1,068,179
|
0.04
|
2,505,799,937 (83.82)
|
1,786,565
|
2. To approve the Directors'
Remuneration Report
|
2,265,917,896
|
92.18
|
192,146,274
|
7.82
|
2,458,064,170 (82.22)
|
49,522,332
|
3. To re-appoint Ernst & Young
LLP as auditor of the Company
|
2,485,635,180
|
99.13
|
21,927,079
|
0.87
|
2,507,562,259 (83.88)
|
24,243
|
4. To authorise the Audit Committee
to determine the auditor's remuneration
|
2,507,429,142
|
99.99
|
143,591
|
0.01
|
2,507,572,733 (83.88)
|
13,769
|
5. To re-elect Ed Smith as a
Director of the Company
|
2,334,664,222
|
93.55
|
160,936,695
|
6.45
|
2,495,600,917 (83.48)
|
11,985,584
|
6. To re-elect Louise Fowler as a
Director of the Company
|
2,474,236,435
|
98.67
|
33,322,682
|
1.33
|
2,507,559,117 (83.88)
|
27,384
|
7. To re-elect Jonathan Murphy as a
Director of the Company
|
2,488,262,988
|
99.23
|
19,297,044
|
0.77
|
2,507,560,032 (83.88)
|
26,470
|
8. To re-elect Jayne Cottam as a
Director of the Company
|
2,485,494,253
|
99.12
|
22,065,779
|
0.88
|
2,507,560,032 (83.88)
|
26,470
|
9. To re-elect Jonathan Davies as a
Director of the Company
|
2,456,425,207
|
98.69
|
32,559,286
|
1.31
|
2,488,984,493 (83.26)
|
18,602,008
|
10. To re-elect Sam Barrell as a
Director of the Company
|
2,465,369,797
|
98.32
|
42,189,320
|
1.68
|
2,507,559,117 (83.88)
|
27,384
|
11. To re-elect Emma Cariaga as a
Director of the Company
|
2,506,913,031
|
99.97
|
646,087
|
0.03
|
2,507,559,118 (83.88)
|
27,384
|
12. To re-elect Noel Gordon as a
Director of the Company
|
2,493,543,158
|
99.44
|
14,019,160
|
0.56
|
2,507,562,318 (83.88)
|
24,184
|
13. To authorise the Directors to
allot shares
|
2,389,749,564
|
95.30
|
117,821,821
|
4.70
|
2,507,571,385 (83.88)
|
15,117
|
14. To empower the Directors to
disapply pre-emption rights
|
2,446,423,969
|
97.60
|
60,167,285
|
2.40
|
2,506,591,254 (83.85)
|
995,248
|
15. To empower the Directors to
disapply pre-emption rights in connection with an acquisition or
specified capital investment
|
2,326,633,121
|
93.05
|
173,780,257
|
6.95
|
2,500,413,378 (83.64)
|
7,173,124
|
16. To authorise the market purchase
of the Company's own shares
|
2,488,128,029
|
99.24
|
19,017,274
|
0.76
|
2,507,145,303 (83.87)
|
441,199
|
17. To authorise the Company to call
any general meeting, other than the Annual General Meeting, by not
less than 14 clear days' notice
|
2,380,425,249
|
94.93
|
127,129,789
|
5.07
|
2,507,555,038 (83.88)
|
31,464
|
18. To amend the Articles of
Association with the addition of article 91
|
2,504,773,882
|
99.98
|
417,429
|
0.02
|
2,505,191,311 (83.80)
|
2,395,191
|
Resolutions 1-13 were passed as
ordinary resolutions. Resolutions 14-18 were passed as special
resolutions. Votes 'For' include votes at the discretion of the
Chairman.
Notes:
1. The percentages above are rounded
to two decimal places.
2. A vote withheld is not a vote in
law and is not counted in the calculation of the proportion of
votes "for" and "against" a resolution.
3. The number of ordinary shares in
issue on the share register at 6.00pm on 3 July 2024 was
2,989,454,390 of which the Total Voting Rights figure was
2,989,454,390.
Copies of resolutions 14-18, being
resolutions other than resolutions concerning ordinary business
passed by the Company at the above AGM, have been submitted to the
National Storage Mechanism and will shortly be available for
inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
- Ends
-
For more information, please
contact:
Assura plc
|
Tel: 0161 515 2043
|
Orla Ball, General Counsel
David Purcell, Investor Relations
Director
|
Email: Investor@assura.co.uk
|
FGS
Global
Gordon Simpson
Grace Whelan
|
Tel: 0207 251 3801
Email: Assura@fgsglobal.com
|
Notes to Editors
Assura plc is the UK's leading
specialist healthcare property investor and developer. Assura
enables better health outcomes through its portfolio of more than
600 healthcare buildings, from which over six million patients are
served.
A UK REIT based in Altrincham,
Assura is a constituent of the FTSE 250 and the EPRA* indices. As
at 31 March 2024, Assura's portfolio was valued at £2.7 billion and
has a strong track record of growing financial returns and
dividends for shareholders.
At Assura, we BUILD for health,
having developed over 100 new healthcare buildings in our history,
and at the heart of our strategy sits The Bigger Picture; Healthy
Environment (E), Healthy Communities (S), Healthy Business
(G).
Further information is available
at www.assuraplc.com
*EPRA is a registered trademark of
the European Public Real Estate Association.
Assura plc LEI
code: 21380026T19N2Y52XF72